Piper Sandler Maintains Underweight on Nevro, Lowers Price Target to $7
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Adam Maeder maintains an Underweight rating on Nevro (NYSE:NVRO) and lowers the price target from $12 to $7.
August 07, 2024 | 11:09 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Piper Sandler analyst Adam Maeder maintains an Underweight rating on Nevro and lowers the price target from $12 to $7.
The lowered price target and maintained Underweight rating by Piper Sandler are likely to negatively impact Nevro's stock price in the short term as it reflects a bearish outlook from a reputable analyst.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100